Joseph J Palamar1, Austin Le1,2, Patricia Acosta1. 1. Department of Population Health, New York University Grossman School of Medicine, New York, NY. 2. New York University College of Dentistry, New York, NY.
Abstract
Background: Little is known about how COVID-19-related social distancing has affected illegal drug use. We surveyed electronic dance music (EDM) partygoers-a population known for high levels of drug use-to determine whether their drug use patterns had changed during state-mandated social distancing in New York. Methods: Individuals were recruited online and screened for eligibility throughout April and May 2020. We surveyed 128 eligible adults and queried, retrospectively, whether their drug use behavior had changed during COVID-19-related social distancing. Results: Most participants reporting past-three-month use reported decreased frequency of use during COVID-19-related social distancing. Specifically, 78.6% reduced frequency of use of cocaine, 71.1% reduced frequency of use of ecstasy/MDMA/Molly, and 68.0% reduced frequency of use of LSD. Although some participants reported increased frequency of use of cocaine (7.1%), ecstasy (7.9%), or LSD (12.0%), 35.0% reported increased frequency of cannabis use. Most (66.7%) of those reporting cocaine use reduced the amount used. The majority of those reporting use of cannabis, ecstasy, cocaine, and/or LSD reported that drug cost (80.0-84.0%) and drug quality (84.2-92.0%) did not change during social distancing. Having a college degree was associated with higher odds for decreasing frequency of cannabis use. Older participants (ages ≥23) were at lower odds for decreasing frequency of cocaine use, as were those earning >$500 per week, and participants who attended EDM events biweekly or more often were at higher odds for decreasing frequency of LSD use. Conclusions: Participants in this sample tended to reduce party drug use during COVID-19-related social distancing.
Background: Little is known about how COVID-19-related social distancing has affected illegal drug use. We surveyed electronic dance music (EDM) partygoers-a population known for high levels of drug use-to determine whether their drug use patterns had changed during state-mandated social distancing in New York. Methods: Individuals were recruited online and screened for eligibility throughout April and May 2020. We surveyed 128 eligible adults and queried, retrospectively, whether their drug use behavior had changed during COVID-19-related social distancing. Results: Most participants reporting past-three-month use reported decreased frequency of use during COVID-19-related social distancing. Specifically, 78.6% reduced frequency of use of cocaine, 71.1% reduced frequency of use of ecstasy/MDMA/Molly, and 68.0% reduced frequency of use of LSD. Although some participants reported increased frequency of use of cocaine (7.1%), ecstasy (7.9%), or LSD (12.0%), 35.0% reported increased frequency of cannabis use. Most (66.7%) of those reporting cocaine use reduced the amount used. The majority of those reporting use of cannabis, ecstasy, cocaine, and/or LSD reported that drug cost (80.0-84.0%) and drug quality (84.2-92.0%) did not change during social distancing. Having a college degree was associated with higher odds for decreasing frequency of cannabis use. Older participants (ages ≥23) were at lower odds for decreasing frequency of cocaine use, as were those earning >$500 per week, and participants who attended EDM events biweekly or more often were at higher odds for decreasing frequency of LSD use. Conclusions: Participants in this sample tended to reduce party drug use during COVID-19-related social distancing.
Authors: Andrew Stickley; Ai Koyanagi; Roman Koposov; Mary Schwab-Stone; Vladislav Ruchkin Journal: BMC Public Health Date: 2014-04-16 Impact factor: 3.295
Authors: Sarah Larney; Dennis C Wendt; Camille Zolopa; Jacob A Burack; Roisin M O'Connor; Charlotte Corran; Jessica Lai; Emiliana Bomfim; Sarah DeGrace; Julianne Dumont Journal: Adolesc Res Rev Date: 2022-02-26
Authors: Antonia Bendau; Leonard Viohl; Moritz Bruno Petzold; Jonas Helbig; Simon Reiche; Roman Marek; Amy Romanello; Daa Un Moon; Rosa Elisa Gross; Dario Jalilzadeh Masah; Stefan Gutwinski; Inge Mick; Christiane Montag; Ricarda Evens; Tomislav Majić; Felix Betzler Journal: Int J Drug Policy Date: 2022-01-05
Authors: Tim Boogaerts; Maarten Quireyns; Maarten De Prins; Bram Pussig; Hans De Loof; Catharina Matheï; Bert Aertgeerts; Virginie Van Coppenolle; Erik Fransen; Adrian Covaci; Alexander L N van Nuijs Journal: Int J Drug Policy Date: 2022-04-04